Paul Stang, PhD is the Vice-President of Global Epidemiology at Janssen Research and Development, leading a group of over 30 researchers who support observational research across Johnson & Johnson. Prior to joining J&J, Dr. Stang was a Vice-President at Cerner Corporation, which he joined after co-founding and serving as the Chief Scientific Officer of Galt Associates, a health care consulting and informatics start-up that was purchased by Cerner. He has worked as a college professor, and has held leadership positions of increasing responsibility in outcomes and epidemiology groups at Glaxo and SmithKline Beecham. Previously, he served as a research investigator for the Observational Medical Outcomes Partnership (OMOP), a public-private partnership whose aim is to design a series of investigations to objectively assess the performance, value and impact of observational data in monitoring the safety and benefit of medications. He has published widely in epidemiology, health outcomes, productivity, and communications, and he continues to serve as a reviewer for a number of journals and is a member of a number of research consortia, governance and scientific advisory boards. He obtained his undergraduate and graduate degrees from the University of North Carolina at Chapel Hill. His passion is understanding and implementing ways that data and graphic representations can help individuals make more informed decisions and change behavior.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.